Literature DB >> 9784121

New goals for the U.S. Human Genome Project: 1998-2003.

F S Collins1, A Patrinos, E Jordan, A Chakravarti, R Gesteland, L Walters.   

Abstract

The Human Genome Project has successfully completed all the major goals in its current 5-year plan, covering the period 1993-98. A new plan, for 1998-2003, is presented, in which human DNA sequencing will be the major emphasis. An ambitious schedule has been set to complete the full sequence by the end of 2003, 2 years ahead of previous projections. In the course of completing the sequence, a "working draft" of the human sequence will be produced by the end of 2001. The plan also includes goals for sequencing technology development; for studying human genome sequence variation; for developing technology for functional genomics; for completing the sequence of Caenorhabditis elegans and Drosophila melanogaster and starting the mouse genome; for studying the ethical, legal, and social implications of genome research; for bioinformatics and computational studies; and for training of genome scientists.

Entities:  

Keywords:  Biomedical and Behavioral Research; Department of Energy; Genetics and Reproduction; Human Genome Project; NIH-DOE Working Group on Ethical, Legal, and Social Implications (ELSI); National Institutes of Health

Mesh:

Year:  1998        PMID: 9784121     DOI: 10.1126/science.282.5389.682

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  120 in total

1.  A 12-Mb complete coverage BAC contig map in human chromosome 16p13.1-p11.2.

Authors:  Y Cao; H L Kang; X Xu; M Wang; S H Dho; J R Huh; B J Lee; F Kalush; D Bocskai; Y Ding; J G Tesmer; J Lee; E Moon; V Jurecic; A Baldini; H U Weier; N A Doggett; M I Simon; M D Adams; U J Kim
Journal:  Genome Res       Date:  1999-08       Impact factor: 9.043

2.  A resource of mapped human bacterial artificial chromosome clones.

Authors:  V G Cheung; H L Dalrymple; S Narasimhan; J Watts; G Schuler; A K Raap; M Morley; A Bruzel
Journal:  Genome Res       Date:  1999-10       Impact factor: 9.043

3.  A comprehensive view of human chromosome 1.

Authors:  P S White; E P Sulman; C J Porter; T C Matise
Journal:  Genome Res       Date:  1999-10       Impact factor: 9.043

4.  Representing genomic knowledge in the UMLS semantic network.

Authors:  H Yu; C Friedman; A Rhzetsky; P Kra
Journal:  Proc AMIA Symp       Date:  1999

5.  MODBASE, a database of annotated comparative protein structure models.

Authors:  R Sánchez; U Pieper; N Mirković; P I de Bakker; E Wittenstein; A Sali
Journal:  Nucleic Acids Res       Date:  2000-01-01       Impact factor: 16.971

6.  WIT: integrated system for high-throughput genome sequence analysis and metabolic reconstruction.

Authors:  R Overbeek; N Larsen; G D Pusch; M D'Souza; E Selkov; N Kyrpides; M Fonstein; N Maltsev; E Selkov
Journal:  Nucleic Acids Res       Date:  2000-01-01       Impact factor: 16.971

7.  The molecular biology database collection: an online compilation of relevant database resources.

Authors:  A D Baxevanis
Journal:  Nucleic Acids Res       Date:  2000-01-01       Impact factor: 16.971

8.  The Molecular Biology Database Collection: an updated compilation of biological database resources.

Authors:  A D Baxevanis
Journal:  Nucleic Acids Res       Date:  2001-01-01       Impact factor: 16.971

Review 9.  The genetics of type 2 diabetes.

Authors:  M McCarthy; S Menzel
Journal:  Br J Clin Pharmacol       Date:  2001-03       Impact factor: 4.335

Review 10.  Molecular profiling of clinical tissues specimens: feasibility and applications.

Authors:  M R Emmert-Buck; R L Strausberg; D B Krizman; M F Bonaldo; R F Bonner; D G Bostwick; M R Brown; K H Buetow; R F Chuaqui; K A Cole; P H Duray; C R Englert; J W Gillespie; S Greenhut; L Grouse; L W Hillier; K S Katz; R D Klausner; V Kuznetzov; A E Lash; G Lennon; W M Linehan; L A Liotta; M A Marra; P J Munson; D K Ornstein; V V Prabhu; C Prang; G D Schuler; M B Soares; C M Tolstoshev; C D Vocke; R H Waterston
Journal:  J Mol Diagn       Date:  2000-05       Impact factor: 5.568

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.